drugs
Global campaign to reduce cholera deaths by 90%
October 4, 2017Medical Communications, Research and Development Cholera, WHO, biotech, drugs, pharma, pharmaceutical
A new campaign, launched by the WHO, has begun today to reduce deaths from cholera by 90% through to 2030. …
Shire takes fight to Allergan over dry-eye drug
October 4, 2017Research and Development Allergan, Restasis, Shire, biotech, drugs, pharma, pharmaceutical
It’s not long since Allergan was in the headlines over its dry-eye drug, Restasis, after an eye-catching attempt to avoid …
Bavarian Nordic seals $539 million vaccine deal
October 3, 2017Manufacturing and Production BARDA, Bavarian Nordic, biotech, drugs, pharma, pharmaceutical
Bavarian Nordic, a Danish biotech, has continued its partnership with the US government by agreeing a $539 million deal to …
‘Universal flu vaccine’ to be trialed this winter
October 3, 2017Manufacturing and Production, Medical Communications Flu virus, Vaccine, biotech, drugs, influenza, pharma, pharmaceutical
Researchers are enrolling 500 participants for the trial of a flu vaccine to protect the population against all strains of …
AstraZeneca Chairman wants three-year Brexit transition period
October 3, 2017Manufacturing and Production, Medical Communications AstraZeneca, biotech, brexit, drugs, pharma, pharmaceutical
The Chairman of AstraZeneca, Leif Johansson, revealed in no uncertain terms that his company would like there to be a …
Collaboration brings forward potential broad flu cure
October 2, 2017Research and Development, Sales and Marketing biotech, drugs, flu, influenza, pharma, pharmaceutical
A joint research effort between The Scripps Research Institute and Janssen has seen the development of a peptide that could …
Ablynx posts strong data on key drug, looks set for approval
October 2, 2017Research and Development, Sales and Marketing Ablynx, biotech, drugs, pharma, pharmaceutical
In a major success for the European biotech industry, Ablynx has revealed that it had met the primary and secondary …
Lilly reveals major senior leadership reshuffle
October 2, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, biotech, drugs, pharma, pharmaceutical
Eli Lilly revealed on 29 September that it would promote four staff members to senior staff positions, and two senior …
MSD pulls out of hep C space to Gilead’s relief
October 2, 2017Sales and Marketing MSD, biotech, drugs, hepatitis C, pharma, pharmaceutical
MSD, known as Merck in North America, has announced that it will curtail its attempts to make an impact in …
Gilead’s COO retires, shares take a dive
September 29, 2017Medical Communications Gilead, Kevin Young, biotech, drugs, pharma, pharmaceutical
Gilead has announced that Kevin Young, its Chief Operating Officer, is set to retire from the company in early 2018. …
Lilly receives FDA breast cancer pill approval, doubts remain
September 29, 2017Medical Communications, Sales and Marketing Eli Lilly, Verzenio, biotech, drugs, pharma, pharmaceutical
Eli Lilly has received an important approval for its breast cancer treatment, Verzenio. The drug will be the third to …
Five more biosimilar-free years for AbbVie’s megablockbuster
September 28, 2017Medical Communications, Sales and Marketing AbbVie, Amgen, Amjevita, Humira, biotech, drugs, pharma, pharmaceutical
Humira is the key drug for AbbVie, and one the company hopes it will be able to push into the …
Novo Nordisk Egypt promotes new General Manager
September 28, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, biotech, drugs, pharma, pharmaceutical
Novo Nordisk Egypt has promoted Hassan Fahmi to become its new General Manager for operations within the company. Fahmi arrived …
Rates of HIV rise amongst older population
September 28, 2017Medical Communications HIV, HIV test, biotech, drugs, pharma, pharmaceutical
It is rare to hear bad news in the fight against the spread of HIV, with the global campaign against …
Sanofi and Regeneron’s projected blockbuster gains EU approval
September 28, 2017Sales and Marketing Dupixent, Regeneron, Sanofi, biotech, drugs, pharma, pharmaceutical
Sanofi and Regeneron have big hopes for their treatment Dupixent, and it has taken an important step towards reaching the …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
